Concepedia

Kelli‐Ann Monaco

KM

Statistics

Publications

2

Citations

114

H-Index

2

Active since

2017

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Kelli‐Ann Monaco is an author at Bristol-Myers Squibb (Germany) specializing in protein kinase inhibitors, pharmacology, and molecular oncology.

Publications per year

2017–2020

2

Publications

2

LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 88 citations · Full text

, , +17

BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity

Kelli‐Ann Monaco, Ping Wang, Marissa N. Balak et al. · Molecular Cancer Research · 2017 · 26 citations

, , +15

1–2 of 2